VR Logo

Ambrx Biopharma Inc. (AMAM) download report


Healthcare | Biotechnology & Pharma Research

Ambrx Biopharma Inc. (AMAM) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform.

IPO Date: 18-Jun-2021

Pres, Member of Scientific Advisory Board, CEO & Chairman: Dr. Feng Tian Ph.D.

Chief Financial Officer: Ms. Sonja Nelson CPA

Listing: NYSE: AMAM

Country: United States

Headquarters: La Jolla, CA

Website: https://ambrx.com

Key Facts

Market cap: $101.87 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-68.08 Mln

Cash: $170.06 Mln

Total Debt: $0.00 Mln

Insider's Holding: 0.00%

Liquidity: Low

52 Week range: $2.52 - 22.87

Shares outstanding: 38,588,600

Stock Performance

Time Period Ambrx Biopharma Inc. (AMAM) S&P BSE Sensex S&P Small-Cap 600
YTD-71.43-8.99-19.23
1 month-36.45-3.40-9.35
3 months-41.76-8.50-16.59
1 Year-85.790.89-17.36
3 Years--10.415.90
5 Years--11.435.77
10 Years--11.779.78
As on 30-Jun-2022